(Q44209138)

30 November 2017

Effects of pharmacological manipulations of cannabinoid receptors on severity of dystonia in a genetic model of paroxysmal dyskinesia (English)

1 reference

30 November 2017

0 references

0 references

0 references

1 reference

1 reference

Angelika Richter

1

1 reference

PubMed ID

12421641

30 November 2017

Wolfgang Löscher

series ordinal

2

1 reference

PubMed ID

12421641

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

European Journal of Pharmacology

30 November 2017

1 reference

30 November 2017

454

1 reference

30 November 2017

2-3

1 reference

30 November 2017

145-151

1 reference

Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Open label evaluation of cannabidiol in dystonic movement disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Paroxysmal dyskinesias: clinical features and classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Effects of pharmacological manipulation of GABAergic neurotransmission in a new mutant hamster model of paroxysmal dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Neuronal activity in the globus pallidus in primary dystonia and off-period dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

The sz mutant hamster: a genetic model of epilepsy or of paroxysmal dystonia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Local effects of cannabinoids on spontaneous activity and evoked inhibition in the globus pallidus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Molecular characterization of a peripheral receptor for cannabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Quantitative autoradiography reveals regionally selective changes in dopamine D1 and D2 receptor binding in the genetically dystonic hamster.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

The evidence for the existence of cannabinoid receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Evidence for striatal dopaminergic overactivity in paroxysmal dystonia indicated by microinjections in a genetic rodent model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

(+)-WIN 55,212-2, a novel cannabinoid receptor agonist, exerts antidystonic effects in mutant dystonic hamsters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Pathology of idiopathic dystonia: findings from genetic animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Cannabidiol in dystonic movement disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Motor actions of cannabinoids in the basal ganglia output nuclei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Activational role of cannabinoids on movement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Anandamide: a candidate neurotransmitter heads for the big leagues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

Mutational and biochemical analysis of dopamine in dystonia: evidence for decreased dopamine D2 receptor inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902477-9

10.1016/S0014-2999(02)02477-9

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference

PubMed ID

12421641